​

Funding Round

Series C - KSQ Therapeutics

Series C - KSQ Therapeutics

Investment Firm

Overview

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

Announced Date

Sep 28, 2018

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorBaillie Gifford
Participant InvestorAlexandria Real Estate Equities
Participant InvestorARCH Venture Partners
Participant InvestorPolaris Partners
Participant InvestorFlagship Pioneering

Round Details and Background

KSQ Therapeutics raised $80000000 on 2018-09-28 in Series C

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 28, 2018
Series C - KSQ Therapeutics
8-80.0M
Oct 02, 2017
Series B - KSQ Therapeutics
4-76.0M

Recent Activity

There is no recent news or activity for this profile.